Camp4 Therapeutics Stock (NASDAQ: CAMP) stock price, news, charts, stock research, profile.
You can purchase shares of Camp4 Therapeutics (NASDAQ:CAMP) through any online brokerage.
Other companies in Camp4 Therapeutics’s space includes: Cabaletta Bio (NASDAQ:CABA), Galectin Therapeutics (NASDAQ:GALT), Adverum Biotechnologies (NASDAQ:ADVM), Monopar Therapeutics (NASDAQ:MNPR) and PepGen (NASDAQ:PEPG).
Camp4 Therapeutics has a consensus price target of $9.97.
The stock price for Camp4 Therapeutics (NASDAQ: CAMP) is $5.8 last updated December 17, 2024 at 4:00 PM EST.
There are no upcoming dividends for Camp4 Therapeutics.
Camp4 Therapeutics’s Q4 earnings are confirmed for Friday, February 14, 2025.
There is no upcoming split for Camp4 Therapeutics.
Camp4 Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.